TrialBritish journal of cancer2007

Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial.

J Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.